Viramune

See also: Generic Viramune XR

Viramune is a brand name of nevirapine, approved by the FDA in the following formulation(s):

VIRAMUNE (nevirapine - suspension; oral)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: September 11, 1998
  
  Strength(s): 50MG/5ML ^[RLD]

VIRAMUNE (nevirapine - tablet; oral)

• 
  Manufacturer: BOEHRINGER INGELHEIM
  
  Approval date: June 21, 1996
  
  Strength(s): 200MG ^[RLD]

Has a generic version of Viramune been approved?

No. There is currently no therapeutically equivalent version of Viramune available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Viramune. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
  Patent 5,366,972
  Issued: November 22, 1994
  Inventor(s): Hargrave; Karl D. & Proudfoot; John R. & Adams; Julian & Grozinger; Karl G. & Schmidt, deceased; Gunther & Engel; Wolfhard & Trummlitz; Gunther & Eberlein; Wolfgang
  Assignee(s): Boehringer Ingelheim Pharmaceuticals, Inc.
  Disclosed are novel 5,11-dihydro-6H-dipyrido[3,2-b; 2',3'-e][1,4]diazepines. These are useful in the prevention or treatment of HIV infection.
  
  Patent expiration dates:
  
  
  • November 22, 2011
    
    ✓ 
    Patent use: METHOD FOR TREATING HIV-1 INFECTION
  
  
  
  • November 22, 2011
    
  
  
  
  • May 22, 2012
    
    ✓ 
    Pediatric exclusivity
  
  

See also...

• Viramune Consumer Information (Wolters Kluwer)
• Viramune Suspension Consumer Information (Wolters Kluwer)
• Viramune Consumer Information (Cerner Multum)
• Viramune Advanced Consumer Information (Micromedex)
• Viramune AHFS DI Monographs (ASHP)
• Nevirapine Consumer Information (Wolters Kluwer)
• Nevirapine Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Nevirapine Suspension Consumer Information (Wolters Kluwer)
• Nevirapine Consumer Information (Cerner Multum)
• Viramune O/S Advanced Consumer Information (Micromedex)
• Nevirapine Advanced Consumer Information (Micromedex)
• Nevirapine AHFS DI Monographs (ASHP)